LOGIQ™

Elevating liver
ultrasound

Comprehensive solutions for liver
disease management from screening
to treatment monitoring
Configure now Contact us
LOGIQ Ultrasound

Confidence in the management of liver disease

To manage patients with liver cancer and/or chronic liver disease – including NAFLD, NASH and ASH – you need an ultrasound system that will help identify disease early, track its progression, and make informed decisions to optimize treatment efficacy. A system that helps you manage your patients with confidence and efficiency at any step of the care pathway. LOGIQ ultrasound can be your trusted companion in liver disease management.
Managing liver care with ultrasound

See and quantify liver disease in a single exam

Liver video screen

Watch the liver care pathway solution

Dr carla serra
quotation mark
Quantify steatosis with confidence

It is key to identify NAFLD patients with high degree of steatosis and fibrosis, due to the higher risk of liver decompensation and HCC. UGAP is a new tool to quantify liver steatosis with accuracy similar to histology and MRI-PDFF.

Dr. Carla Serra
Chief of the Interventional Ultrasound Unit, Dept of organ failure and transplantation
IRCCSS. Orsola-Malpighi University Hospital
Bologna, Italy
Explore this clinical experience
Franco orsi
quotation mark
Fusion imaging in every procedure

In Interventional Oncology, Fusion Imaging helps improve procedure standardization, making feasible almost every needle insertion. It also improves safety, clinical outcomes and reduce the learning curve for beginners becoming an essential technique for my ‘everyday’ clinical practice.

Prof. Franco Orsi
Director of the Interventional Radiology DepartmentIRCCS European Institute of Oncology,
Milano, Italy
Explore this clinical experience
Prof olivier seror
quotation mark
Increased accuracy and safety with Fusion Imaging

We do perform complex ablations with multi-bipolar RFA needles under real Time Fusion Imaging Ultrasound/Cone Beam CT. Ultrasound with advanced fusion tools is an essential guidance technique to go further in the percutaneous ablation of Liver cancers.

Prof. Olivier Seror, MD, PHD
Director of the Interventional Radiology Department Hôpital Avicenne, Hôpitaux Universitaires Paris-Seine-Saint-Denis
Assistance-Publique Hôpitaux de Paris
Bobigny, France
Explore this clinical experience
Prof sporea
quotation mark
Multi-parametric ultrasound is key

A multiparametric ultrasound approach (MPUS), as a point of care investigation in liver disease, is the best one, in terms of time and costs. For liver steatosis quantification, UGAP seems to be a good method that correlates strongly with Controlled Attenuation Parameter (CAP) values.

Prof. Ioan Sporea, MD, PHD
Victor Babes University of Medicine and Pharmacy of Timisoara - UMFT Discipline of Gastroenterology, MD, PhD, Professor of Gastroenterology
Explore this clinical experience
Prof berzigotti
quotation mark
B-Flow, key role in liver disease

What strikes me most by using B-Flow technique on the liver is the possibility to visualize in a very detailed manner the portal vein and hepatic vein vessels [...] and in my view constitutes a technology bridge between standard techniques and CEUS in this scenario

Prof. Annalisa Berzigotti
Head of Hepatology, Clinic Director a.i.
University Clinic for Visceral Surgery and Medicine
Inselspital, University Hospital
Bern, Switzerland
Explore this clinical experience
Byenfeldt
quotation mark
“Everyone should have one”

(...) The UGAP has now become a key part of my diagnostic tool bag when I perform examination of the liver, often combined with the shear wave elastography to detect early stage of liverfibrosis.

Marie Byenfeldt, PHD
Sonographer
Östersund Hospital, Sweden
Explore this clinical experience
Interested in requesting a quotation?

Configure my LOGIQ

Logiq e10 card
LOGIQ E10 Series
Logiq fortis card
LOGIQ Fortis
Logiq p series card
LOGIQ P Series

Have a question?
We would love to hear from you.

Contact us